ADVERTISEMENT

ADVERTISEMENT

MADURACIÓN PULMONAR FETAL CON CORTICOIDES, UNA SITUACIÓN COMPLEJA EN LA MADRE CON DIABETES

Jorge Fabián Tedesco

Resumen


La maduración pulmonar con corticoides fue un avance significativo en la lucha contra las complicaciones respiratorias que sufrían los niños prematuros, convirtiéndose en un hito en la historia de la Medicina moderna.

Se sabe que los hijos de madres con diabetes gestacional (DG) o prestacional (DPG) tienen una mayor incidencia de distrés respiratorio del recién nacido, por lo que se verían beneficiados con esta práctica médica. También se conoce el efecto hiperglucemiante de los corticoides que provocan una inhibición de la producción del surfactante. De esta manera no se obtendrían los efectos beneficiosos a nivel respiratorio, y además se pondría en riesgo tanto a la madre como al hijo. Por esto resulta fundamental el control metabólico estricto durante la maduración pulmonar con corticoides mediante la implementación de protocolos de monitoreo glucémico y de infusión de insulina para lograr los resultados deseados y evitar, o minimizar, los riesgos.


Palabras clave


maduración pulmonar fetal; corticoides; diabetes gestacional; distrés respiratorio

Texto completo:

PDF

Referencias


Schwarcz RL, Duverges CA, Díaz AG, et al. Obstetricia. 6ta. Edición. Buenos Aires: Editorial El Ateneo, 2005; cap. 2:24-25.

Iñiguez F, Sánchez I. Desarrollo pulmonar. Revista Neumonología Pediátrica, Sociedad Chilena de Neumología Pediátrica 2008; Vol 3, 2:148-155.

Fetal lung maturity. ACOG Practice Bulletin Nº 97. American College of Obstetricians and Gynecologist. Obstet Gynecol 2008; 112:117-26.

Delgado J, Greene M, Winkelman J, et al. Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies. Am J Clin Pathol 2000; 113:233-239.

Melanson SE, Jarolim P, Mc Elrath TF, et al. Fetal lung maturity testing in diabetic mothers. Lab Med 2007; 38:553.

Consenso de diabetes. Recopilación, actualización y recomendaciones para el diagnóstico y tratamiento de la diabetes gestacional. FASGO 2012 Sep; Vol 11, Nº 2.

Cordero L, Treuer SH, Landon MB, et al. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 1998; 152(3):249.

Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol 2002 Apr; 186 (4): 641-50.

Piper JM, Xenakis EM, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. Matern Fetal Med 1998; 7(3):148.

Piper JM. Lung maturation in diabetes in pregnancy: if and when to test. Semin Perinatol 2002 Jun; 26(3):206-9.

Piazze JJ, Anceschi MM, Maranghi L, et al. Fetal lung maturity in pregnancies complicated by insulin-dependent and gestational diabetes: a matched cohort study. Eur J Obstet Gynecol Reprod Biol 1999 Apr; 83(2):145-50.

Carlson KS, Smith BT, Post M. Insulin acts on the fibroblast to inhibit glucocorticoid stimulation of lung maturation. J Appl Physiol 1984; 57:1577-1579.

Guideline for the use of antenatal corticosteroids for fetal maturation. J Perinat Med 2008; 36:191-196.

Antenatal corticosteroids to reduce neonatal morbidity and mortality. Green-top Guideline Nº 7 October 2010. Royal College of Obstetricians and Gynaecologists.

Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017 Mar 21; Issue 3.

Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; (3).

Brownfoot FC, Crowther CA, Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth (Review).The Cochrane Library 2008; Issue 4.

Lee BH, Stoll BJ, McDonald SA, Higgins RD. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 2006;117;1503

Baud O, Foix-L’Helias L, Kaminski M, et al. Antenatal

glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341:1190-6.

Gurbuz A, Karateke A, Ozturk G et al. Is 1-hour glucose screening test reliable after a short-term administration of antenatal betamethasone? Am J Perinatol 2004 Oct; 21(7):415-20.

Mastrobattista JM, Patel N, Monga M. Betamethasone alteration of the one-hour glucose challenge test in pregnancy. J Reprod Med 2001;46:83-86.

JianYun X, Zhaoxia L, Yun C, et al. Changes in maternal glucose metabolism after the administration of dexamethasone for fetal lung development. Int J Endocrinol 2012; 2012.

Foglia LM, Deering SH, Lim E, et al. Maternal glucose levels after dexamethasone for fetal lung development in twin vs singleton pregnancies. Am J Obstet Gynecol 2008 Oct; 199 (4):380.

Refuerzo JS, Garg A, Rech B, et al. Continuous glucose monitoring in diabetic women following antenatal corticosteroid therapy: a pilot study. Am J Perinatol 2012 May; 29 (5):335-8.

Bedalov A, Balasubramanyam A. Glucocorticoid-induced ketoacidosis in gestational diabetes: sequela of the acute treatment of preterm labor. A case report. Diabetes Care 1997 Jun; 20 (6):922-4.

Iafusco D, Stoppoloni F, Salvia G, et al. Use of real time continuous glucose monitoring and intravenous insulin in type 1 diabetic mothers to prevent respiratory distress and hypoglycaemia in infants. BMC Pregnancy Childbirth 2008, 8:23.

Warburton D. Chronic hyperglycemia with secondary hyperinsulinemia inhibits the maturational response of fetal lamb lungs to cortisol. J Clin Invest 1983; 433-440.

Ramírez-Torres MA, Pérez-Monter SE, Espino y Sosa S, et al. Efecto de la betametasona en la glucemia de diabéticas embarazadas en riesgo de nacimiento pretérmino. Ginecol Obstet Mex 2011; 79(9):565-571.

Refuerzo JS, Garg A, Rech B, et al. Continuous glucose monitoring in diabetic women following antenatal corticosteroid therapy: a pilot study. Am J Perinatol 2012; 29:335-338.

Antenatal corticosteroids to reduce neonatal morbidity and mortality. Green-top Guideline N1 7. October 2010. Royal College of Obstetricians and Gynaecologists.

Recomendaciones para gestantes con diabetes pregestacional. Conclusiones del Consenso reunido por convocatoria del Comité de Diabetes y Embarazo de la SAD. Octubre 2009.

Consenso Latinoamericano de Diabetes y Embarazo. ALAD noviembre de 2007.

Mathiesen ER, Christensen AB, Hellmuth E, et al. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm (correction of analgoritm). Acta Obstet Gynecol Scand 2002 Sep; 81(9):835-9.

Kaushal K, Gibson JM, Railton A, et al. A protocol for improved glycaemic control following corticosteroid therapy in diabetic pregnancies. Diabet Med 2003 Jan; 20 (1):73-5.

Dalziel SR, Liang A, Parag V, et al. Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial. Pediatrics 2004 Sep; 114(3):e373-7.

Dalziel SR, Rea HH, Walker NK, et al. Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. Thorax 2006 Aug; 61(8):678-83.

Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomized controlled trial. Lancet 2005; 365: 1856-62.

Dalziel SR, Lim VK, Lambert A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005 Sep 24; 331(7518):665.

Dalziel SR, Fenwick S, Cundy T, et al. Peak bone mass after exposure to antenatal betamethasone and prematurity: follow-up of a randomized controlled trial. J Bone Miner Res 2006; 21:1175-1186.




Copyright (c) 2019 Sociedad Argentina de Diabetes Asociación Civil

ADVERTISEMENT

ADVERTISEMENT